pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

12,903 catalysts · 3,350 8k filing · 2,377 grant · 2,035 approval · 1,373 device 510k · 1,000 device adverse event · 929 device pma

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-10: 0 catalysts2026-08-11: 0 catalysts2026-08-12: 0 catalysts2026-08-13: 0 catalysts2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 1 catalyst2026-08-18: 2 catalysts2026-08-19: 3 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 1 catalyst2026-08-27: 1 catalyst2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 1 catalyst2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 2 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 2 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 1 catalyst2026-10-14: 1 catalyst2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 1 catalyst2026-10-20: 2 catalysts2026-10-21: 2 catalysts2026-10-22: 2 catalysts2026-10-23: 1 catalyst2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 1 catalyst2026-10-27: 8 catalysts2026-10-28: 12 catalysts2026-10-29: 21 catalysts2026-10-30: 4 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts2026-11-02: 9 catalysts2026-11-03: 18 catalysts2026-11-04: 22 catalysts2026-11-05: 37 catalysts2026-11-06: 2 catalysts2026-11-07: 0 catalysts2026-11-08: 0 catalysts
view
agendamonth
sort
soonestlatesttypesponsoralpha
from 2025-11-04×clear all
type
  • 8k filing3,350
  • grant2,377
  • approval2,035
  • device 510k1,373
  • device adverse event1,000
  • device pma929
  • device recall810
  • earnings584
  • recall364
  • phase 2 completion172
  • therapy area
    • Oncology148
    • Infectious Disease46
    • Cardiology37
    • Immunology35
    • Dermatology31
    • Pulmonology22
    • Women's Health19
    • Ophthalmology16
    • Pain15

    Week of Nov 10, 2025

    41
    ›Nov 14, 2025approval274d agoARIPIPRAZOLE — FDA approvalTeva Pharmaceuticals USA Inc

    Sponsor: TEVA PHARMS USA. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Nov 14, 2025approval274d agoARIPIPRAZOLE — FDA approvalTeva Pharmaceuticals USA Inc

    Sponsor: TEVA PHARMS USA. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Nov 14, 2025approval274d agoARIPIPRAZOLE — FDA approvalTeva Pharmaceuticals USA Inc

    Sponsor: TEVA PHARMS USA. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Nov 14, 2025approval274d agoARIPIPRAZOLE — FDA approvalTeva Pharmaceuticals USA Inc

    Sponsor: TEVA PHARMS USA. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Nov 14, 2025approval274d agoARIPIPRAZOLE — FDA approvalTeva Pharmaceuticals USA Inc

    Sponsor: TEVA PHARMS USA. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Nov 14, 2025approval274d agoFOSFOMYCIN TROMETHAMINE — FDA approvalFOSFOMYCIN TROMETHAMINE

    Sponsor: AUROBINDO PHARMA LTD. Form: FOR SOLUTION. Route: ORAL

    full page →FOSFOMYCIN TROMETHAMINE →fda approvals ↗
    ›Nov 14, 2025approval274d agoALDACTONE (SPIRONOLACTONE) — FDA approvalALDACTONE

    Sponsor: PFIZER. Form: TABLET. Route: ORAL

    full page →ALDACTONE →fda approvals ↗
    ›Nov 14, 2025approval274d agoDILTIAZEM HYDROCHLORIDE — FDA approvalDILTIAZEM HYDROCHLORIDE

    Sponsor: ALEMBIC. Form: TABLET. Route: ORAL

    full page →DILTIAZEM HYDROCHLORIDE →fda approvals ↗
    ›Nov 14, 2025approval274d agoOXYCODONE HYDROCHLORIDE — FDA approvalOXYCODONE HYDROCHLORIDE

    Sponsor: ASCENT PHARMS INC. Form: TABLET. Route: ORAL

    full page →OXYCODONE HYDROCHLORIDE →fda approvals ↗
    ›Nov 14, 2025approval274d agoVORICONAZOLE — FDA approvalVORICONAZOLE

    Sponsor: HAINAN POLY PHARM. Form: SOLUTION. Route: INTRAVENOUS

    full page →VORICONAZOLE →fda approvals ↗
    ›Nov 14, 2025approval274d agoRIVAROXABAN — FDA approvalRIVAROXABAN

    Sponsor: APOTEX. Form: TABLET. Route: ORAL

    full page →RIVAROXABAN →fda approvals ↗
    ›Nov 14, 2025approval274d agoTRUQAP (CAPIVASERTIB) — FDA approvalcapivasertib

    Sponsor: ASTRAZENECA. Form: TABLET. Route: ORAL

    full page →capivasertib →fda approvals ↗
    ›Nov 14, 2025device 510k274d agoPrinceton BioMeditech Corp. — Status™ COVID-19/Flu A&B (510k cleared)

    Product code: SCA. Advisory committee: Microbiology. Type: Dual Track

    full page →fda device 510k ↗
    ›Nov 14, 2025device 510k274d agoParagon Implant Mfg., LLC — Sterilization Trays (510k cleared)

    Product code: KCT. Advisory committee: General Hospital. Type: Traditional

    full page →fda device 510k ↗
    ›Nov 14, 2025device 510k274d agoThis AG — System Sophi (510k cleared)

    Product code: HQC. Advisory committee: Ophthalmic. Type: Traditional

    full page →fda device 510k ↗
    ›Nov 14, 2025device 510k274d agoKLS-Martin L.P. — KLS Martin IPS Forearm System (510k cleared)

    Product code: HRS. Advisory committee: Orthopedic. Type: Traditional

    full page →fda device 510k ↗
    ›Nov 14, 2025device 510k274d agoFresenius Medical Care Renal Therapies Group, LLC — AquaC UNO H (510k cleared)Fresenius Medical Care AG

    Product code: FIP. Advisory committee: Gastroenterology, Urology. Type: Traditional

    full page →fda device 510k ↗
    ›Nov 14, 2025device 510k274d agoOnward Medical, Inc. — ARC-EX System (510k cleared)Picard Medical, Inc.

    Product code: SDO. Advisory committee: Physical Medicine. Type: Traditional

    full page →fda device 510k ↗
    ›Nov 14, 2025device 510k274d agoQingdao Future Medical Technology Co., Ltd. — Mesh Nebulizer (H6) (510k cleared)

    Product code: CAF. Advisory committee: Anesthesiology. Type: Traditional

    full page →fda device 510k ↗
    ›Nov 14, 2025device 510k274d agoEos Imaging — AutoDensity (510k cleared)

    Product code: QIH. Advisory committee: Radiology. Type: Traditional

    full page →fda device 510k ↗
    ›Nov 14, 2025device 510k274d agoBiomoneta Research Private Limited — Biomoneta Avata Rx (510k cleared)

    Product code: FRF. Advisory committee: General Hospital. Type: Traditional

    full page →fda device 510k ↗
    ›Nov 14, 2025device 510k274d agoFusmobile, Inc. — Neurolyser XR (NXR100) (510k cleared)

    Product code: SGN. Advisory committee: Neurology. Type: Direct

    full page →fda device 510k ↗
    ›Nov 14, 2025device 510k274d agoPearl, Inc. — Second Opinion® Panoramic (510k cleared)

    Product code: MYN. Advisory committee: Radiology. Type: Traditional

    full page →fda device 510k ↗
    ›Nov 14, 2025device 510k274d agoInanovate, Inc. — Lyme-ID IgG Test; Bio-ID800 (510k cleared)

    Product code: LSR. Advisory committee: Microbiology. Type: Traditional

    full page →fda device 510k ↗
    ›Nov 14, 2025device 510k274d agoAlovea Healthcare Co. , Ltd. — IPL Hair Removal Device (I6 S1, I6 D1, I6 M1) (510k cleared)NVP Healthcare Co Ltd

    Product code: OHT. Advisory committee: General, Plastic Surgery. Type: Traditional

    full page →fda device 510k ↗
    ›Nov 14, 2025device pma274d agoAtriCure, Inc. — EPi-Sense ST Coagulation System (PMA supplement)AtriCure, Inc.

    Supplement type: Real-Time Process. Product code: OCM. Advisory committee: CV. Decision: APPR

    full page →fda device pma ↗
    ›Nov 14, 2025device pma274d agoSTAAR Surgical Company — VISIAN ICL (IMPLANTABLE COLLAMER LENS) (PMA supplement)STAAR SURGICAL CO

    Supplement type: Normal 180 Day Track. Product code: MTA. Advisory committee: OP. Decision: APPR

    full page →fda device pma ↗
    ›Nov 14, 2025device recall274d agoOlympus Corporation of the Americas device recall (Cls II)

    Brand Name: ShockPulse-SE Lithotripsy System Product Name: ShockPulse-SE Lithotripsy System - Generator Model/Catalog Number: SPL-G Product Description: The ShockPulse Lithotripsy System is an electromechanical device capable of fragmenting calculi and aspirating stone debris. The ShockPulse transducer is a reusable device that requires cleaning and steam sterilization prior to use in order to generate both low-frequency mechanical impacts and high-frequency ultrasonic energy that quickly disintegrates stones. — Reason: Ongoing investigations identified additional instances of the device Generator remaining in a blinking phase waiting to recognize the transducer. Damage to the transducer plug and/or generator receptacle may cause these issues. — Status: Ongoing

    full page →fda device recalls ↗
    ›Nov 14, 2025device recall274d agoAVID Medical, Inc. device recall (Cls II)AVITA Medical, Inc.

    Halyard, MIDTOWN GENERAL ARTERIOGRAM. Catalog Number: EUHM009-01. — Reason: Potential for incomplete seal on header bag. — Status: Ongoing

    full page →fda device recalls ↗
    ›Nov 14, 2025device recall274d agoAVID Medical, Inc. device recall (Cls II)AVITA Medical, Inc.

    Halyard, EP LAB PK. Catalog Number: ESJH009-03. — Reason: Potential for incomplete seal on header bag. — Status: Ongoing

    full page →fda device recalls ↗
    ›Nov 14, 2025device recall274d agoGE Medical Systems China Co., Ltd. device recall (Cls I)

    GE Healthcare Carestation anesthesia system, product number and REF numbers: Carestation 610 A1, REF 1012-9620-222; Carestation 620 A1 REF 1012-9620-000; Carestation 620 A1, REF 1012-9620-200; Carestation 620 A1, REF 1012-9620-202; Carestation 620 SE A1, REF 1012-9620-212; Carestation 630 A1, REF 1012-9650-222; Carestation 650 A1, REF 1012-9650-000; Carestation 650 A1, REF 1012-9650-200; Carestation 650 A1, REF 1012-9650-202; Carestation 650 SE A1, REF 1012-9650-212; Carestation 650c A1, REF 1012-9655-202; Anesthesia Gas Machine Products for which affected PMB can be used as a spare part: Carestation 620 A2, REF 1012-9620-002 00840682124546 Carestation 620 SE A2, REF 1012-9620-012 00195278569677 Carestation 650 A2, REF 1012-9650-002 00840682124560 Carestation 650 SE A2, REF 1012-9650-012 00195278569684 Carestation 650c A1, REF 1012-9655-000 00840682103954 Carestation 650c A2, REF 1012-9655-002 00840682124539 Carestation 650c A1, REF 1012-9655-200 00195278439543 — Reason: Potential unexpected shutdown of Carestation 600 and 700 Series Anesthesia Systems containing certain power management boards, if the AC mains power is unplugged or in the event of an AC mains power failure. Anesthesia systems only operate on battery power in a rare event that AC mains power is lost and there is no continuous backup emergency power. If AC power is interrupted, the system will not automatically switch over to the battery supply mode and will reboot. If this issue occurs, a temporary disruption of mechanical ventilation, manual ventilation, and volatile agent delivery may occur. Following the reboot, the system will not return to the previous ventilation settings. — Status: Ongoing

    ›Nov 14, 2025device recall274d agoAVID Medical, Inc. device recall (Cls II)AVITA Medical, Inc.

    Halyard, MAJOR PACK. Catalog Number: JEMJ10-01. — Reason: Potential for incomplete seal on header bag. — Status: Ongoing

    full page →fda device recalls ↗
    ›Nov 14, 2025device recall274d agoAVID Medical, Inc. device recall (Cls II)AVITA Medical, Inc.

    Halyard, HEAD AND NECK TRAY. Catalog Number: EURO016-09. — Reason: Potential for incomplete seal on header bag. — Status: Ongoing

    full page →fda device recalls ↗
    ›Nov 14, 2025device recall274d agoFresenius Kabi USA, LLC device recall (Cls I)Fresenius Kabi USA LLC

    Ivenix Infusion System (IIS), LVP Software LVP-SW-0005. Software for the controlled administration of fluids to patients. — Reason: Software version 5.10.1 and earlier contain anomalies that have the potential to cause serious patient harm or death. — Status: Ongoing

    full page →fda device recalls ↗
    ›Nov 14, 2025device recall274d agoGE Medical Systems China Co., Ltd. device recall (Cls I)

    GE Healthcare Carestation anesthesia system, product number and REF numbers: Carestation 750 A1, REF 1012-9750-000; Carestation 750 A2, REF 1012-9750-002; Carestation 750c A1, REF 1012-9755-000; Products for which affected PMB can be used as a spare part: Carestation 750c A2, REF 1012-9755-002 — Reason: Potential unexpected shutdown of Carestation 600 and 700 Series Anesthesia Systems containing certain power management boards, if the AC mains power is unplugged or in the event of an AC mains power failure. Anesthesia systems only operate on battery power in a rare event that AC mains power is lost and there is no continuous backup emergency power. If AC power is interrupted, the system will not automatically switch over to the battery supply mode and will reboot. If this issue occurs, a temporary disruption of mechanical ventilation, manual ventilation, and volatile agent delivery may occur. Following the reboot, the system will not return to the previous ventilation settings. — Status: Ongoing

    full page →fda device recalls ↗
    ›Nov 14, 2025device recall274d agoOlympus Corporation of the Americas device recall (Cls II)

    Brand Name: ShockPulse-SE Lithotripsy System SPL-SR Product Name: ShockPulse-SE Lithotripsy System - Reusable Probes Model/Catalog Number: SPL-SR Product Description: The ShockPulse Lithotripsy System is an electromechanical device capable of fragmenting calculi and aspirating stone debris. The ShockPulse transducer is a reusable device that requires cleaning and steam sterilization prior to use in order to generate both low-frequency mechanical impacts and high-frequency ultrasonic energy that quickly disintegrates stones. — Reason: Ongoing investigations identified additional instances of the device Generator remaining in a blinking phase waiting to recognize the transducer. Damage to the transducer plug and/or generator receptacle may cause these issues. — Status: Ongoing

    full page →fda device recalls ↗
    ›Nov 14, 2025device recall274d agoAVID Medical, Inc. device recall (Cls II)AVITA Medical, Inc.

    Halyard, GENERAL LAPAROSCOPY PACK. Catalog Number: VAST018-10. — Reason: Potential for incomplete seal on header bag. — Status: Ongoing

    full page →fda device recalls ↗
    ›Nov 14, 2025device recall274d agoGE Medical Systems China Co., Ltd. device recall (Cls I)

    GE Healthcare Carestation anesthesia system Power Management Board (PMB) Field Replaceable Unit (FRU), 2076139-001-S — Reason: Potential unexpected shutdown of Carestation 600 and 700 Series Anesthesia Systems containing certain power management boards, if the AC mains power is unplugged or in the event of an AC mains power failure. Anesthesia systems only operate on battery power in a rare event that AC mains power is lost and there is no continuous backup emergency power. If AC power is interrupted, the system will not automatically switch over to the battery supply mode and will reboot. If this issue occurs, a temporary disruption of mechanical ventilation, manual ventilation, and volatile agent delivery may occur. Following the reboot, the system will not return to the previous ventilation settings. — Status: Ongoing

    full page →fda device recalls ↗
    ›Nov 14, 2025device recall274d agoOlympus Corporation of the Americas device recall (Cls II)

    Brand Name: ShockPulse-SE Lithotripsy System SPL-S Product Name: ShockPulse-SE Lithotripsy System - Single Use Probes Model/Catalog Number: SPL-S Product Description: The ShockPulse Lithotripsy System is an electromechanical device capable of fragmenting calculi and aspirating stone debris. The ShockPulse transducer is a reusable device that requires cleaning and steam sterilization prior to use in order to generate both low-frequency mechanical impacts and high-frequency ultrasonic energy that quickly disintegrates stones. — Reason: Ongoing investigations identified additional instances of the device Generator remaining in a blinking phase waiting to recognize the transducer. Damage to the transducer plug and/or generator receptacle may cause these issues. — Status: Ongoing

    full page →fda device recalls ↗
    ›Nov 16, 2025grant272d agoYALE UNIVERSITY — Defining a mechanism for inner nuclear membrane protein SUN2's mechanical reg...

    AR grant. $49,538. PI: Sandra Del Carmen Sandria

    full page →nih reporter ↗
    ›Nov 16, 2025grant272d agoMASSACHUSETTS INSTITUTE OF TECHNOLOGY — Deracemization of Beta2- and Gamma2-amino acids

    GM grant. $75,052. PI: Shivaani Sanjay Gandhi

    full page →nih reporter ↗

    Week of Nov 17, 2025

    9
    ›Nov 17, 2025approval271d agoOXYMORPHONE HYDROCHLORIDE — FDA approvalOXYMORPHONE HYDROCHLORIDE

    Sponsor: EPIC PHARMA LLC. Form: TABLET. Route: ORAL

    full page →OXYMORPHONE HYDROCHLORIDE →fda approvals ↗
    ›Nov 17, 2025approval
    ← prev
    page 8 of 259
    next →
    full page →
    fda device recalls ↗
    271d ago
    TECENTRIQ HYBREZA (ATEZOLIZUMAB AND HYALURONIDASE-TQJS) — FDA approval(atezolizumab + hyaluronidase (human recombinant))

    Sponsor: GENENTECH INC. Form: INJECTABLE. Route: INJECTION

    full page →(atezolizumab + hyaluronidase (human recombinant)) →fda approvals ↗
    ›Nov 17, 2025approval271d agoLOPERAMIDE HYDROCHLORIDE — FDA approvalLOPERAMIDE HYDROCHLORIDE

    Sponsor: MARKSANS PHARMA. Form: TABLET. Route: ORAL

    full page →LOPERAMIDE HYDROCHLORIDE →fda approvals ↗
    ›Nov 17, 2025approval271d agoTOFACITINIB CITRATE — FDA approvaltofacitinib citrate ER

    Sponsor: BIOCON PHARMA. Form: TABLET, EXTENDED RELEASE. Route: ORAL

    full page →tofacitinib citrate ER →fda approvals ↗
    ›Nov 17, 2025approval271d agoONDANSETRON HYDROCHLORIDE — FDA approvalondansetron hydrochloride CR

    Sponsor: GLAND PHARMA LTD. Form: INJECTABLE. Route: INJECTION

    full page →ondansetron hydrochloride CR →fda approvals ↗
    ›Nov 17, 2025approval271d agoMEMBRANEBLUE (TRYPAN BLUE) — FDA approval

    Sponsor: DORC. Form: SOLUTION. Route: OPHTHALMIC

    full page →fda approvals ↗
    ›Nov 17, 2025approval271d agoONDANSETRON — FDA approvalondansetron ODT

    Sponsor: SANDOZ. Form: TABLET, ORALLY DISINTEGRATING. Route: ORAL

    full page →ondansetron ODT →fda approvals ↗
    ›Nov 17, 2025approval271d agoTECENTRIQ (ATEZOLIZUMAB) — FDA approvalatezolizumab

    Sponsor: GENENTECH INC. Form: INJECTABLE. Route: INJECTION

    full page →atezolizumab →fda approvals ↗
    ›Nov 17, 2025approval271d agoPANRETIN (ALITRETINOIN) — FDA approvalalitretinoin

    Sponsor: ADVANZ PHARMA. Form: GEL. Route: TOPICAL

    full page →alitretinoin →fda approvals ↗
    $STAA26.18+3.36%
    $RCEL7.8500-2.00%
    $RCEL7.8500-2.00%
    $FMS23.77+0.59%
    $PMI0.1821-4.66%
    $PFE26.79-0.04%
    $RCEL7.8500-2.00%
    $AZN156.45-0.50%
    $ATRC
    $RCEL7.8500-2.00%
    $RCEL7.8500-2.00%